In line with the high correspondence between these two markers in breast cancer, especially within the aggressive subtypes, our meta-analysis results revealed a similar correlation between CD68- and CD163-positive macrophages with clinicopathological parameters and prognosis. This evidence concerns the gene CD163 and breast cancer.